Arzerra


Patients with chronic lymphoid leukemia ( CLL ) or small lymphocytic lymphoma ( SLL ) who experience short response duration...


Ofatumumab ( Arzerra ) is a fully human monoclonal antibody that binds to both the large and small extracellular loops...


According to NICE ( National Institute for Health and Clinical Excellence ) Ofatumumab ( Arzerra ) is not recommended for...


GlaxoSmithKline ( GSK ) and Genmab have announced the results from the concluded pivotal trial of Ofatumumab ( Arzerra )...


The study enrolled patients with chronic lymphocytic leukemia ( CLL ), heavily pre-treated, who did not respond to, or who...